Elevance Health, Inc. ELV
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 42.74B | 41.98B | 41.79B | 41.18B | 42.42B |
| Total Other Revenue | 8.69B | 8.49B | 8.39B | 8.57B | 8.30B |
| Total Revenue | 51.43B | 50.47B | 50.18B | 49.75B | 50.71B |
| Cost of Revenue | 37.78B | 37.02B | 35.62B | 38.07B | 38.14B |
| Gross Profit | 13.65B | 13.45B | 14.57B | 11.68B | 12.57B |
| SG&A Expenses | 11.37B | 11.04B | 11.79B | 10.75B | 10.65B |
| Depreciation & Amortization | 106.00M | 110.00M | 112.00M | 164.00M | 162.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 49.26B | 48.17B | 47.52B | 48.98B | 48.95B |
| Operating Income | 2.17B | 2.30B | 2.66B | 766.00M | 1.76B |
| Income Before Tax | 1.79B | 1.94B | 2.30B | 215.00M | 1.41B |
| Income Tax Expenses | 451.00M | 483.00M | 544.00M | -331.00M | 219.00M |
| Earnings from Continuing Operations | 1.34B | 1.45B | 1.76B | 546.00M | 1.19B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 22.00M | 9.00M | 4.00M | 1.00M | 2.00M |
| Net Income | 1.37B | 1.46B | 1.76B | 547.00M | 1.19B |
| EBIT | 2.17B | 2.30B | 2.66B | 766.00M | 1.76B |
| EBITDA | 2.53B | 2.67B | 3.02B | 1.17B | 2.14B |
| EPS Basic | 6.30 | 6.74 | 8.03 | 2.47 | 5.32 |
| Normalized Basic EPS | 5.33 | 5.62 | 6.57 | 1.13 | 3.94 |
| EPS Diluted | 6.27 | 6.71 | 8.00 | 2.47 | 5.32 |
| Normalized Diluted EPS | 5.31 | 5.60 | 6.55 | 1.13 | 3.94 |
| Average Basic Shares Outstanding | 216.60M | 217.00M | 219.80M | 221.80M | 223.30M |
| Average Diluted Shares Outstanding | 217.60M | 217.90M | 220.40M | 221.80M | 223.70M |
| Dividend Per Share | 1.72 | 1.72 | 1.72 | 1.71 | 1.71 |
| Payout Ratio | 27.33% | 25.50% | 21.32% | 68.92% | 32.04% |